WS
TTPH

Wedbush Securities’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Wedbush Securities’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-525
Closed -$40K – 904
2016
Q3 		$40K Buy
+525
New +$42.1K 0.01% 800

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wedbush Securities's TTPH Position: Q4 2016 in Review

Wedbush Securities sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 525 shares — an estimated $40K sold.

Wedbush Securities first reported a position in TTPH in Q3 2016 and held it in 1 quarter. The position peaked at $40K in Q3 2016. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

  • Wedbush Securities reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Wedbush Securities sold 525 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $40K.
  • Wedbush Securities first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2016 and held it in 1 quarter.
  • Wedbush Securities's Tetraphase Pharmaceuticals, Inc. position peaked at $40K in Q3 2016.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Wedbush Securities's 13F filing for Q4 2016, filed 25 Jan 2017.